141 related articles for article (PubMed ID: 19282794)
21. Biodistribution of intravenously injected [131I]Lipiodol in rats.
Seto H; Tsuji S; Watanabe N; Futatsuya R; Nomura K; Maeda M; Kakishital M
Radiat Med; 1992; 10(5):196-8. PubMed ID: 1332132
[TBL] [Abstract][Full Text] [Related]
22. Preparation and preliminary biological evaluation of 177Lu-labelled hydroxyapatite as a promising agent for radiation synovectomy of small joints.
Chakraborty S; Das T; Banerjee S; Sarma HD; Venkatesh M
Nucl Med Commun; 2006 Aug; 27(8):661-8. PubMed ID: 16829766
[TBL] [Abstract][Full Text] [Related]
23. Development of 99mTc labelled Lipiodol: biodistribution following injection into the hepatic artery of the healthy pig.
Garin E; Noiret N; Malbert CH; Lepareur N; Roucoux A; Dazord L; Caulet-Maugendre S; Turlin B; Moisan A; Lecloirec J; Herry JY; Boucher E; Raoul JL; Bourguet P
Nucl Med Commun; 2004 Mar; 25(3):291-7. PubMed ID: 15094449
[TBL] [Abstract][Full Text] [Related]
24. 90Y-oxine-ethiodol, a potential radiopharmaceutical for the treatment of liver cancer.
Yu J; Häfeli UO; Sands M; Dong Y
Appl Radiat Isot; 2003 May; 58(5):567-73. PubMed ID: 12735973
[TBL] [Abstract][Full Text] [Related]
25. [Radiotherapy with (186)Re-lipiodol II for primary liver cancer patients].
Shi L; Zhang Z; Zhuang D; Cheng H; Gao Y; Wu M
Zhonghua Wai Ke Za Zhi; 2002 Nov; 40(11):814-6. PubMed ID: 12487852
[TBL] [Abstract][Full Text] [Related]
26. Lipiodol solution of a lipophilic agent, (188)Re-TDD, for the treatment of liver cancer.
Jeong JM; Kim YJ; Lee YS; Ko JI; Son M; Lee DS; Chung JK; Park JH; Lee MC
Nucl Med Biol; 2001 Feb; 28(2):197-204. PubMed ID: 11295430
[TBL] [Abstract][Full Text] [Related]
27. Preparation of Holmium-166 Labelled Macroaggregates for radionuclide synovectomy.
Kropácek M; Melichar F; Henková K; Konopková M
Nucl Med Rev Cent East Eur; 2003; 6(1):1-4. PubMed ID: 14600925
[TBL] [Abstract][Full Text] [Related]
28. Potential (166)Ho radiopharmaceuticals for intravascular radiation therapy (IVRT)-I: [(166)Ho] holmium labeled ethylene dicysteine.
Chakraborty S; Unni PR; Banerjee S; Samuel G; Das T; Sarma HD; Ramamoorthy N; Pillai MR
Nucl Med Biol; 2001 Apr; 28(3):309-17. PubMed ID: 11323243
[TBL] [Abstract][Full Text] [Related]
29. Potential 166Ho radiopharmaceuticals for endovascular radionuclide therapy. II. Preparation and evaluation of 166Ho-DTPA.
Majali MA; Saxena SK; Joshi SH; Unni PR; Ramamoorthy N
Nucl Med Commun; 2001 Jan; 22(1):97-103. PubMed ID: 11233559
[TBL] [Abstract][Full Text] [Related]
30. Electron- and positron-emitting radiolanthanides for therapy: aspects of dosimetry and production.
Uusijärvi H; Bernhardt P; Rösch F; Maecke HR; Forssell-Aronsson E
J Nucl Med; 2006 May; 47(5):807-14. PubMed ID: 16644751
[TBL] [Abstract][Full Text] [Related]
31. Preparation and bioevaluation of 166Ho labelled hydroxyapatite (HA) particles for radiosynovectomy.
Unni PR; Chaudhari PR; Venkatesh M; Ramamoorthy N; Pillai MR
Nucl Med Biol; 2002 Feb; 29(2):199-209. PubMed ID: 11823125
[TBL] [Abstract][Full Text] [Related]
32. Biodistribution of 10B in a rat liver tumor model following intra-arterial administration of sodium borocaptate (BSH)/degradable starch microspheres (DSM) emulsion.
Suzuki M; Nagata K; Masunaga S; Kinashi Y; Sakurai Y; Maruhashi A; Ono K
Appl Radiat Isot; 2004 Nov; 61(5):933-7. PubMed ID: 15308171
[TBL] [Abstract][Full Text] [Related]
33. Radiolabelling of Lipiodol with generator-produced 188Re for hepatic tumor therapy.
Wang SJ; Lin WY; Chen MN; Hsieh BT; Shen LH; Tsai ZT; Ting G; Knapp FF
Appl Radiat Isot; 1996 Mar; 47(3):267-71. PubMed ID: 8935963
[TBL] [Abstract][Full Text] [Related]
34. [Plasma platinum concentration and anti-tumor effects after intra-arterial infusion of lipiodol-CDDP suspension evaluation with VX 2 rabbit liver cancer model and 7.0 Tesla MRI system].
Sonoda A; Nitta N; Ohta S; Itoh R; Takahashi M; Murata K; Morikawa S; Inubushi T; Miyagawa Y; Takamori M; Oonaka Y
Gan To Kagaku Ryoho; 2006 Jul; 33(7):951-7. PubMed ID: 16835486
[TBL] [Abstract][Full Text] [Related]
35. [Effect of intra-arterially injected cisplatinum and lipiodol on the rat liver].
Kawakami A; Ishida O; Suzuki T
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2787-92. PubMed ID: 2843134
[TBL] [Abstract][Full Text] [Related]
36. In vitro assessment of Lipiodol-targeted radiotherapy for liver and colorectal cancer cell lines.
Al-Mufti RA; Pedley RB; Marshall D; Begent RH; Hilson A; Winslet MC; Hobbs KE
Br J Cancer; 1999 Apr; 79(11-12):1665-71. PubMed ID: 10206275
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of 188 Re-labelled long chain alkyl diaminedithiol for therapy of liver cancer.
Lee YS; Jeong JM; Kim YJ; Chung JW; Park JH; Suh YG; Lee DS; Chung JK; Lee MC
Nucl Med Commun; 2002 Mar; 23(3):237-42. PubMed ID: 11891481
[TBL] [Abstract][Full Text] [Related]
38. The use of lipiodol and medium chain triglyceride as delivery agents for hepatic arterial administration of 1, 25-dihydroxyvitamin D3--a potential new treatment for hepatocellular carcinoma.
Finlay IG; Stewart GJ; Pourgholami MH; Akhter J; Morris DL
Anticancer Res; 2000; 20(4):2705-9. PubMed ID: 10953347
[TBL] [Abstract][Full Text] [Related]
39. Preparation and in vitro stability of (n,gamma) yttrium-90 hydroxyapatite.
Khalid M; Mushtaq A
Appl Radiat Isot; 2005 Apr; 62(4):587-90. PubMed ID: 15701413
[TBL] [Abstract][Full Text] [Related]
40. [Effect of the portal vein injection of cisplatin and lipiodol on rat liver].
Ono Y; Yoshioka H; Kawakami A; Ishida O; Suzuki T
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3429-34. PubMed ID: 2552932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
